Kreft et al identified factors associated with progression of marrow fibrosis in a patient in the pre-fibrotic phase of chronic idiopathic myelofibrosis. These can help identify a patient who may require more aggressive management. The authors are from Medizinische Hochschule in Hannover, Germany.
Parameters:
(1) age of the patient in years
(2) grade of megakaryocytic proliferation (release of growth factors from megakaryocytes one possible cause for fibroblastic proliferation)
Megakaryocytic Proliferation |
Grade |
normal (no proliferation) |
0 |
slight proliferation |
1 |
moderate proliferation, with or without clusters |
2 |
marked proliferation, with or without sheets |
3 |
Parameter |
Finding |
Points |
age in years |
< 60 years |
0 |
|
>= 60 years |
1 |
grade of megakaryocytic proliferation |
0 or 1 |
0 |
|
2 or 3 |
1 |
total score =
= SUM(points for both parameters)
Interpretation:
• minimum score: 0
• maximum score: 2
Total Score |
Median Period with Grade 0 or 1 Myelofibrosis |
0 |
138 months |
1 or 2 |
58-60 months |
where:
• Grade 0 or 1 myelofibrosis indicates no or slight increase in reticulin fibers.
• Grade 2 or 3 myelofibrosis showed increasing amounts of reticulin with or without collagen fibers resulting in a decrease in the space available for blood forming cells.
Specialty: Hematology Oncology
ICD-10: ,